GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » Selling and Marketing Expense

HLB Pharmaceutical Co (XKRX:047920) Selling and Marketing Expense : ₩74,977 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. HLB Pharmaceutical Co's Selling and Marketing Expense for the three months ended in Mar. 2025 was ₩19,033 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩74,977 Mil.

HLB Pharmaceutical Co Selling and Marketing Expense Historical Data

The historical data trend for HLB Pharmaceutical Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co Selling and Marketing Expense Chart

HLB Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,163.11 26,035.28 59,731.71 91,432.31 73,785.33

HLB Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,841.34 18,902.18 18,955.17 18,086.64 19,033.13

HLB Pharmaceutical Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩74,977 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HLB Pharmaceutical Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of HLB Pharmaceutical Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » Selling and Marketing Expense
Comparable Companies
XKRX:000640 XKRX:084110 XKRX:200670 XKRX:003850 XKRX:019170 XKRX:001060 XKRX:086450 XKRX:206650 XKRX:389470 XKRX:170900 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR
Website
http://www.hlbpharma.co.kr
HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co Headlines

No Headlines